Trials / Completed
CompletedNCT01081015
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,494 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the Connect™ Chronic Lymphocytic Leukemia (CLL) Disease Registry is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.
Conditions
Timeline
- Start date
- 2010-03-19
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2010-03-05
- Last updated
- 2020-05-12
Locations
165 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01081015. Inclusion in this directory is not an endorsement.